PUBLICATION
Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics
- Authors
- Ding, Y., Sun, X., Redfield, M., Kushwaha, S., and Xu, X.
- ID
- ZDB-PUB-120125-28
- Date
- 2012
- Source
- Cell cycle (Georgetown, Tex.) 11(3): 428-429 (Other)
- Registered Authors
- Ding, Yonghe, Sun, Xiaojing, Xu, Xiaolei
- Keywords
- none
- MeSH Terms
-
- Animals
- Cardiomyopathies/drug therapy*
- Cardiomyopathies/genetics
- Mutation
- Protein Kinase Inhibitors/pharmacology
- Protein Kinase Inhibitors/therapeutic use*
- Signal Transduction/drug effects
- Sirolimus/pharmacology
- Sirolimus/therapeutic use*
- TOR Serine-Threonine Kinases/antagonists & inhibitors*
- TOR Serine-Threonine Kinases/genetics
- TOR Serine-Threonine Kinases/metabolism
- Zebrafish/genetics*
- PubMed
- 22262179 Full text @ Cell Cycle
Citation
Ding, Y., Sun, X., Redfield, M., Kushwaha, S., and Xu, X. (2012) Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics. Cell cycle (Georgetown, Tex.). 11(3):428-429.
Abstract
Comment on: Ding Y, et al. Circ Res 2011; 109:658-69.
Errata / Notes
Editorial of: Ding Y, et al. Circ Res 2011; 109; 658-669
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping